- Home
- TPST vs CLDI Comparison
TPST vs CLDI Comparison
Compare TPST & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- CLDI
- Stock Information
- Founded
- TPST 2011
- CLDI 2014
- Country
- TPST United States
- CLDI United States
- Employees
- TPST N/A
- CLDI N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TPST Health Care
- CLDI Health Care
- Exchange
- TPST Nasdaq
- CLDI Nasdaq
- Market Cap
- TPST 40.4M
- CLDI 35.2M
- IPO Year
- TPST N/A
- CLDI N/A
- Fundamental
- Price
- TPST $0.86
- CLDI $1.05
- Analyst Decision
- TPST Strong Buy
- CLDI Strong Buy
- Analyst Count
- TPST 3
- CLDI 3
- Target Price
- TPST $21.67
- CLDI $16.67
- AVG Volume (30 Days)
- TPST 877.6K
- CLDI 2.7M
- Earning Date
- TPST 03-18-2025
- CLDI 03-14-2025
- Dividend Yield
- TPST N/A
- CLDI N/A
- EPS Growth
- TPST N/A
- CLDI N/A
- EPS
- TPST N/A
- CLDI N/A
- Revenue
- TPST N/A
- CLDI N/A
- Revenue This Year
- TPST N/A
- CLDI N/A
- Revenue Next Year
- TPST N/A
- CLDI N/A
- P/E Ratio
- TPST N/A
- CLDI N/A
- Revenue Growth
- TPST N/A
- CLDI N/A
- 52 Week Low
- TPST $0.70
- CLDI $0.58
- 52 Week High
- TPST $6.00
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- TPST 40.89
- CLDI 45.04
- Support Level
- TPST $0.85
- CLDI $1.16
- Resistance Level
- TPST $0.95
- CLDI $1.30
- Average True Range (ATR)
- TPST 0.05
- CLDI 0.24
- MACD
- TPST -0.00
- CLDI 0.01
- Stochastic Oscillator
- TPST 9.45
- CLDI 40.10
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.